149 related articles for article (PubMed ID: 21150971)
1. Lessons from Bayh-Dole.
Sampat BN
Nature; 2010 Dec; 468(7325):755-6. PubMed ID: 21150971
[No Abstract] [Full Text] [Related]
2. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
Colaianni A; Cook-Deegan R
Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286
[TBL] [Abstract][Full Text] [Related]
3. Is Bayh-Dole good for developing countries? Lessons from the US experience.
So AD; Sampat BN; Rai AK; Cook-Deegan R; Reichman JH; Weissman R; Kapczynski A
PLoS Biol; 2008 Oct; 6(10):e262. PubMed ID: 18959484
[TBL] [Abstract][Full Text] [Related]
4. Bayh-Dole: if we knew then what we know now.
Boettiger S; Bennett AB
Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
[No Abstract] [Full Text] [Related]
5. Research and the Bayh-Dole Act.
Reczek PR
Science; 2004 Jan; 303(5654):40. PubMed ID: 14704412
[No Abstract] [Full Text] [Related]
6. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business.
Fernandes M; Miska D
Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036
[No Abstract] [Full Text] [Related]
7. Don't feed the trolls.
Nature; 2014 Jun; 510(7503):7. PubMed ID: 24910865
[No Abstract] [Full Text] [Related]
8. Navigating biotechnology's new fiscal opportunities.
Purcell DJ
Nat Biotechnol; 1998 May; 16 Suppl():51-3. PubMed ID: 9591271
[No Abstract] [Full Text] [Related]
9. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Westerlund L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
[No Abstract] [Full Text] [Related]
10. Taking knowledge from bench to bank.
Horton B; Wickware P; Gershon D; Gavaghan H
Nature; 1998 Sep; 395(6700):409-14. PubMed ID: 9759734
[No Abstract] [Full Text] [Related]
11. Intellectual property. University licensing and the Bayh-Dole Act.
Thursby JG; Thursby MC
Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
[No Abstract] [Full Text] [Related]
12. The Bayh-Dole Act turns 30.
Loise V; Stevens AJ
Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
[TBL] [Abstract][Full Text] [Related]
13. Universities struggle to make patents pay.
Ledford H
Nature; 2013 Sep; 501(7468):471-2. PubMed ID: 24067689
[No Abstract] [Full Text] [Related]
14. Start up and succeed.
Kaplan K
Nature; 2009 Nov; 462(7272):530-1. PubMed ID: 20066758
[No Abstract] [Full Text] [Related]
15. Biotech patents-business as usual?
Lawrence S
Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
[No Abstract] [Full Text] [Related]
16. Hatch-waxman changes debated.
Chahine K
Nat Biotechnol; 2000 Jul; 18(7):710-1. PubMed ID: 10888831
[No Abstract] [Full Text] [Related]
17. Can we expect to achieve anything from Indian Bayh Dole?
Janodia MD; Sreedhar D; Ligade VS; Udupa N
Indian J Med Res; 2009 Oct; 130(4):487. PubMed ID: 19942757
[No Abstract] [Full Text] [Related]
18. Calling for entrepreneurs London.
Smaglik P
Nature; 2002 Sep; 419(6904):4-5. PubMed ID: 12239519
[No Abstract] [Full Text] [Related]
19. Start-ups: A sense of enterprise.
Savage N
Nature; 2016 May; 533(7601):S10-2. PubMed ID: 27144602
[No Abstract] [Full Text] [Related]
20. Q&A: Horst Domdey.
Wald C
Nature; 2016 May; 533(7601):S30-1. PubMed ID: 27144606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
